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Transforming g r o w t h  faetor-j81 (TGF-/81) contributes 
to t u m o r  invasion a n d  cancer progression b y  increasing 
the motility of t u m o r  cells. T o  identify genes involved in 
TGF-j8-mediated cell migration, the transcriptional p r o ­
files of h u m a n  m a m m a r y  epithelial cells ( H M E C )  treated 
with TGF-/8 w e r e  c o m p a r e d  with untreated cells by 
c D N A  microarray analysis. O n e  gene up-regulated by  
TGF-/3 w a s  recently n a m e d  kindlerin (Jobard, F., 
Bouadjar, B., Caux, F., Hadj-Rabia, S., Has, C., Matsuda, 
F., Weissenbach, J., Lathrop, M., P r u d’h o m m e ,  J. F., a n d  
Fischer, J. (2003) Hum. Mol. Genet. 12, 925-935). This 
gene is significantly overexpressed in s o m e  cancers 
(Weinstein, E. J., B o u m e r ,  M., Head, R., Zakeri, H., 
Bauer, C., a n d  Mazzarella, R. (2003) Biochim . B iophys. 
A c ta 1637, 207-216), a n d  mutations in this gene lead to 
Kindler syndrome, a n  autosomal-recessive genod er ma - 
tosis. TGF-/3 stimulation of H M E C  resulted in a m a r k e d  
induction of kindlerin R N A ,  a n d  W e s te rn  blotting d e m ­
onstrated a corresponding increase in protein a b u n ­
dance. Kindlerin displays a putative F E R M  (four point 
one ezrin radixin moesin) d o m a i n  that is closely related 
to the sequences in talin that interact with integrin j8 
subunit cytoplasmic domains. T h e  critical residues in 
the talin F E R M  d o m a i n  that mediate integrin binding 
s h o w  a high degree of conservation in kindlerin. F u r ­
thermore, kindlerin is recruited into a molecular c o m ­
plex with the p 1A a n d  j83 integrin cytoplasmic domains. 
Consistent with these biochemical findings, kindlerin is 
present at focal adhesions, sites of integrin-rich, m e m -  
brane-substratum adhesion. Additionally, kindlerin is 
required for n o r m a l  cell spreading. T a k e n  together, 
these data suggest a role for kindlerin in mediating cell 
processes that d e p e n d  o n  integrins.
The survival of cancer p a tie n ts  w ith  solid tum ors decreases 
d ram atica lly  w hen tum ors a re  invasive an d  have an  increased  
likelihood of m e tas ta s iz in g  to d is ta l s ites. T he enhanced  in v a ­
siveness of tum or cells is a ttr ib u te d  to ep ithelia l to m esenchy-
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m al tran s itio n  (EM T),1 (5 -8 ) a  norm al biological process th a t  is 
critical for w ound h ea ling  an d  developm ent. EM T is ch a rac te r­
ized by a  change in  cell shape  from a  polarized ep ithe lia l cell to 
a  fla tten ed  fibroblast-like m orphology, a  decrease in  cell-cell 
ju n c tio n s concurren t w ith  a  decrease in  E -cadherin  expression, 
an d  an  increase  in  cell m otility  (5, 6). T ransfo rm ing  grow th 
factor-|31 (TGF-J3) is a  m ajor con tribu to r to tum or progression 
an d  m e ta s ta s is  (9 -11), and  several s tud ies  have  show n th a t  
TGF-J3 prom otes tu m o r cell invasiveness by prom oting EM T (9, 
12-15). D espite the  key role e s tab lished  for TGF-J3 in  s t im u la t­
ing  EM T and  tum or progression, th e  m olecular m echan ism s by 
w hich TGF-J3 prom otes EM T have no t been fully e lucidated .
M icroarray  ana ly s is of a  TGF-j3-responsive cell line, hu m an  
m am m ary  ep ithelia l cells (HMEC), led u s  to identify  k ind lerin  
a s  a  TGF-j3-inducible gene. K ind lerin  is m u ta ted  in K indler 
syndrom e, a  ra re  autosom al-recessive genoderm atosis (1, 3). 
E arly  in  life p a tie n ts  w ith  K indler syndrom e en d u re  b liste ring  
of th e  sk in  an d  photosensitiv ity , w hich progresses to diffuse 
poikiloderm a followed by cu taneous atrophy  (16, 17). T he clin ­
ical p resen ta tio n  of th is  d isease  is s im ila r to p a tie n ts  w ith  
junc tiona l epiderm olysis bu llosa harb o rin g  m u ta tio n s  in  a 6 and  
P4 in teg rin  genes (18, 19).
K indlerin  ( also know n as URP1 for UNC-112 re la ted  p ro te in  
1 or k indlin) is a  m em ber of a  new ly recognized p ro te in  family, 
w hich also includes Mig-2 an d  U RP2 (2, 3). An ap p a ren t 
k ind lerin  orthologue, UNC-112, h a s  been stud ied  in  Caenor­
habd itis  elegans (20). T he unc-112  gene is essen tia l for em bry­
ogenesis, an d  i t  d isp lays a  genetic in te rac tion  w ith  in teg rin s  
(20). B ecause in teg rin s  p lay  a  critical role in  m am m alian  cell 
adhesion an d  m igration , w e p o stu la ted  th a t  k ind lerin  m ay be 
involved in  TG F-j3-stim ulated EM T th rough  in te rac tio n s w ith  
in teg rins.
H ere  w e rep o rt th a t  k ind lerin  expression is responsive to 
TGF-J3 levels, th a t  k ind lerin  localizes in  focal adhesions (inte- 
g rin-rich  signaling  cen te rs th a t  in teg ra te  ex trace llu la r m a trix  
a tta ch m en t and  cytoskeletal organization), an d  th a t  k ind lerin  
form s complexes w ith  in teg rin  ji su b u n it cytoplasm ic dom ains. 
F u rth erm o re , cell sp read ing  is p e rtu rb ed  upon reduction  of 
k ind lerin  p ro tein . T aken  to ge ther w ith  th e  observation  th a t  
k ind lerin  is overexpressed in  colon an d  lung  carcinom as (2), 
our d a ta  suppo rt a  role for k ind lerin  in  m am m alian  cell ad h e ­
sion and  suggest th a t  k ind lerin  m ay m ed ia te  TGF-J3 signaling  
in  tum or progression v ia  con tribu tions to in teg rin -dependen t 
ce llu lar functions.
1 The abbreviations used are: EMT, epithelial to mesenchymal tran­
sition; TGF-f!l, transforming growth factor f3; HMEC, human mam­
mary epithelial cells; Mig-2, mitogen inducible gene-2; FERM, four 
point one ezrin radixin moesin; PH, pleckstrin homology; siRNA, small 
interfering siRNA; PBS, phosphate-buffered saline; MES, 4-morpho- 
lineethane.sulfonic acid; BisTris, 2-[bis(2-hydroxyethyl)aminoJ-2-(hy- 
droxymethyl)propane-l,3-diol; PH, pleckstrin homology.






















Cell Culture and Drug Treatments—HaCaT cells were maintained in 
Dulbecco’s modified Eagle’s medium supplemented with 10% fetal 
bovine serum and were split every 3rd day or at 80% eonflueney. 
The HaCaT immortalized keratinoeyte cell line was a gift from D. 
Grossman. HMEC were obtained from BioWhittaker and cultured in 
complete mammary epithelial growth media. HMEC were seeded at 
passages 7 or 8 and harvested at no greater than 80% eonflueney for all 
experiments.
cDNA Microarray Data Analysis—The construction of the microar­
rays, generation of the microarray probes, microarray hybridization, 
and scanning were performed as described previously (21). First-strand 
cDNAs were generated by reverse transcription from the mRNA sam­
ples in the presence of Cy-3dCTP or Cy-5dCTP. The resulting labeled 
cDNAs were combined and simultaneously hybridized to the microar­
ray slide displaying 4608 randomly selected and minimally redundant 
cDNAs from the unigene set (22). Each of the 4608 minimally redun­
dant genes was present in duplicate on the microarray, and the com­
parisons were completed three separate times resulting in a total of six 
measurements for each gene. In each case, mRNA from TGF-£S-treated 
cells was directly compared with mRNA from vehicle-treated cells. The 
GeneSpring software program (version 5.1; Silicon Genetics) was uti­
lized for all steps in the data analysis. To normalize the microarray 
data, a Lowess curve was fit to the log intensity versus log ratio plot. 
20.0% of the data was used to calculate the Lowess fit at each point. 
This curve was used to adjust the control value for each measurement. 
We selected TGF-£S-responsive genes based on a statistical analysis 
using the gene expression program GeneSpring (version 5.1). We ap­
plied the inclusion criteria of 1.5-fold induction, and a p  value of less 
than 0.05 (Student’s t test) in defining TGF-f! up-regulated genes. The 
list of genes shown in Table I was selected from the total normalized 
data set as having a fold induction greater than 1.5 in at least 4 of 6 
data points (see the experimental description within Table I). Genes 
with a p  value (Students t test) greater than 0.05 were not included. 
DNA sequencing and BLAST analysis confirmed the identity of each 
microarray clone corresponding to those genes listed in Table I.
Northern Blotting—For treatments with TGF-f!l (PeproTech), 
HMEC cells were not serum-starved prior to the addition of growth 
factor. The vehicle control for TGF-f!l was composed of 4 mM HC1, 1 
mg/ml bovine serum albumin. Cycloheximide (Calbiochem) was used at 
10 /ng/ml and was added to the cells 15 min prior to the addition of 
TGF-fi. Total RNA was isolated using Trizol (Invitrogen) followed by 
poly(A) RNA selection using a Poly(AT) Tract mRNA Isolation kit 
(Promega). Poly(A) RNA was fractionated through formaldehyde-con­
taining agarose gels and transferred onto nylon membranes (Amer­
sham Biosciences). Probes were generated using the Rediprime II ran­
dom prime labeling system (Amersham Biosciences) supplemented with 
[a2PJdCTP. Hybridizations with a2P-labeled probes were carried out 
using ULTRAhyb buffer (Ambion) as recommended by the manufac­
turer. The kindlerin probe was generated by amplification of the insert 
of a cDNA image clone (accession number 299593) using T7 and T3 
primers.
Construction o f FLAG-tagged Kindlerin cDNA—In order to manufac­
ture the longest piece of the 5' end of kindlerin cDNA, the EcoRI/Swal 
fragment of AA158566 was subcloned into the EcoRI/Swal sites of 
A l147142 to make clone A. Clone A was used as a template for PCR to 
add an EcoRI site directly 5' of the ATG (sense oligonucleotide 5, 
5'-ACG AAT TCA ATG CTG TCA TCC ACT GACTTT AC-3') and ended 
at the native PstI site (antisense oligonucleotide 6, 5'-CGA GGA TGC 
TGC AGT TTT GTT CC-3'). The EcoRI/PstI insert from clone A was 
excised and replaced with the PCR product digested with EcoRI/PstI in 
order to remove the 5'-untranslated region to generate clone B. The 3' 
end of kindlerin cDNA was isolated by reverse transcriptase-PCR using 
RNA isolated from HMEC treated with TGF-fi. The sense oligonucleo­
tide 7 (5'-ATA GGT ACC TCA ATC CTG ACC GCC GGT CAA-3') began 
at the Haell site, and the antisense oligonucleotide 8 (5'-GAA GCG 
GCG CTT TCT AAT TTG GA-3') added a Kpnl site directly 3' of the stop 
codon. The complete FLAG-kindlerin cDNA was assembled by three- 
piece ligation containing clone B digested with EcoRI and Haell, the 
reverse transcriptase-PCR product digested with Haell and Kpnl, and 
FLAGpCMV2 digested with EcoRI and Kpnl.
Kindlerin Antibody Generation—A construct expressing the C-termi­
nal third of kindlerin (amino acid residues 500 to end) with a His tag 
was engineered as follows: a PCR product was generated using sense 
oligonucleotide 11 (5'-GCT CCA TAT GAT TCT TTC CTT TCT GAA 
GAT GCA GCA T-3') and antisense oligonucleotide 12 (5'-ATG CGG 
CCG CTC ACA CCC AAC CAC TGG TAA GTT T-3') using the FLAG-
kindlerin cDNA as template and cloned into Ndel and Notl sites of the 
pET28a vector (Novagen). The construct was verified by DNA sequenc­
ing and utilized to transform competent BL21 cells (Novagen). The 
recombinant His-tagged kindlerin fragment was purified under dena­
turing conditions in 6 M urea. Fractions containing purified protein 
were pooled and concentrated using a Centricon-30 (Millipore). Concen­
trated protein was loaded onto SDS-PAGE, briefly stained with BioSafe 
Coomassie Blue (Bio-Rad), and excised from the gel. Gel pieces contain­
ing kindlerin were used to inject rabbits for polyclonal antibody pro­
duction (Harlan Bioproducts for Science).
Western Blotting—For the TGF-f! time course, HMEC orHaCaTwere 
treated with vehicle or TGF-f! (2 ng/ml) for the indicated times. Protein 
lysates were harvested from HaCaT or HMEC in a buffer containing 25 
mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM CaCl2, 1% Triton X-100, 0.1 
mM phenylmethylsulfonyl fluoride, 0.1 mM benzamidine, 1 mg/ml pep- 
statin A, and 1 mg/ml phenanthroline. The lysates were centrifuged at 
20,800 x g  for 10 min at 4 °C. The supernatant was transferred to a 
clean tube and assayed for protein concentration using the DC Protein 
Assay (Bio-Rad). For antibody characterization (Fig. 3A), lysates were 
heated at 70 °C for 10 min in LDS sample buffer (Invitrogen) and then 
separated by Tris-glycine 10%> SDS-PAGE and transferred to nitrocel­
lulose (Millipore). The blots were incubated with indicated kindlerin, 
vinculin (Sigma), or E-cadherin (Transduction Laboratories) antibodies, 
followed by incubation with donkey anti-rabbit horseradish peroxidase 
or sheep anti-mouse horseradish peroxidase (Amersham Biosciences). 
Immune complexes were visualized with Western Lightning Chemilu- 
minescence Reagent (PerkinElmer Life Sciences). For the time course 
experiments, lysates were harvested and analyzed as indicated above, 
with the exception tha t BisTris 4-12% NuPAGE using MES running 
buffer (Invitrogen) was utilized to separate the lysates.
Phase Contrast Imaging—HMEC were allowed to adhere overnight 
and were subsequently treated with vehicle or TGF-f! for 48 h. Cell 
morphology was observed using a Nikon microscope and recorded with 
a digital camera.
A ffin ity  Purifica tion o f Kindlerin Antibody and Indirect Im m unoflu­
orescence—Kindlerin antiserum was affinity-purified by using a 
method described previously (23). Briefly, antiserum was incubated 
with recombinant kindlerin immobilized on nitrocellulose. After exten­
sive washing of the membrane, the bound antibodies were eluted with 
100 mM glycine, pH 2.5, and immediately combined with 1 M Tris-HCl, 
pH 9.0, sufficient to neutralize the glycine-HCl. The eluted material 
was then concentrated in a Centricon-10 device (Amicon). The control 
antibody was absorbed to nitrocellulose without kindlerin protein. In­
direct immunofluorescence was performed by plating HaCaT cells on 
glass coverslips coated with 10 /ng/ml fibronectin (Sigma) in Dulbecco’s 
modified Eagle’s medium (Invitrogen) supplemented with 10%' fetal 
bovine serum (Invitrogen). To examine kindlerin localization in the 
presence of TGF-fi, cells were treated with vehicle or TGF-f! (2 ng/ml) 
for 48 h. Coverslips were washed in PBS, fixed for 15 min with 4%o 
formaldehyde, 5 pM CaCl2, 0.5 pM MgCl2 in PBS, and permeabilized for
4 min with 0.2% Triton X-100 in PBS. After washing in PBS, the 
coverslips were incubated with primary antibodies at 37 °C for 120 min, 
washed in PBS for 10 min, and subsequently incubated with Alexa-488- 
or Alexa-594-conjugated secondary antibodies (Molecular Probes). The 
coverslips were mounted with ProLong (Molecular Probes) after wash­
ing for 10 min in PBS. Primary antibodies used in this study include 
affinity-purified rabbit polyclonal kindlerin antibody R-2230 (1:100), 
control antibody (1:100), rabbit polyclonal talin antibody B -ll (1:800), 
and vinculin monoclonal antibody (1:300 Sigma). Actin filaments were 
visualized using Alexa-488-conjugated phalloidin (1:100 Molecular 
Probes). Cell images were visualized on a Zeiss Axiophot microscope 
and recorded with a digital camera.
Kindlerin and Talin A m ino Acid A lignm ent and Modeling—The pri­
mary sequences of kindlerin and talin were aligned by blast searching 
(www.ncbi.nlm.nih.gov/blast/) and refined using structure-based align­
ments performed by Swiss-PdbViewer (us.expasy.org/spdbv/) using the 
structure of talin subdomains F2 and F3 (4) (Protein Data Bank code 
1MK7) as template. Based on the sequence alignment, the putative 
kindlerin F3 subdomain (residues 566-655) was modeled on the talin 
F3 subdomain (residues 309-400 from Protein Data Bank code 1MK7). 
Modeling was performed using Swiss model (24-26), and the quality of 
the resulting model was assessed using WHAT_CHECK and WHAT-IF 
version 19970813-1517 (27, 28).
Integrin fi Tail B inding Assays—Affinity chromatography was per­
formed by using recombinant models of integrin cytoplasmic tails as 
described previously (29). Briefly, Chinese hamster ovary cells trans­
fected with FLAG-kindlerinpCMV2 were lysed as described previously 






















Genes Induced by TGF-/3 in HMEC  
Human mammarv epithelial cells were treated with TGF-/3 (10 ng/ml,i 
for 3 h; mRNA harvested from treated and non-treated HMEC samples 
(3 independent replicates) was reverse-transcribed into cDNA in the 
presence of either a green or red fluorescent tag. Competitive hybrid­
ization of the labeled cDNAs on glass slides containing 4608 cDNAs 
spotted in duplicate revealed the relative increase and decrease of 
specific mRNAs. Stringent data analysis (greater than 1.5-fold in 4 of 
the 6 microarray ratios; p  value less than 0.05) facilitated the identifi­
cation of 17 TGF-/3 up-regulated transcripts.
Gene name Fold change p value0
Plasminogen activator inhibitor. 3.07 7.76E-07
type 1 (PA11)
Integrin <t2 2.55 4.46E-04
Kindlerin 2.30 5.36E-05
Transglutaminase 2.17 5.07E-03
TGF-j3 induced. 68-kDa 1.96 4.92E-03
Connective tissue growth factor 1.94 4.32E-05
PMEPA1 1.89 5.56E-03
Sox-4 1.88 1.66E-02
Tubulin «-4 chain 1.76 2.13E-02
TisllD/ERF-2 1.70 3.22E-04
Gadd45£> 1.69 7.24E-04
EST (accession no. A1828370) 1.66 6.81E-03
DNA G /f mismatch-binding protein 1.63 6.79E-05
Thrombospondin 1 1.62 1.68E-02
TGF-j3 inducible early protein (T1EG) 1.61 4.04E-05
Early growth response (EGR-1) 1.58 3.63E-02
Fibronectin 1.58 8.22E-05
" p  values were calculated using the Student’s t test from 6 independ­
ent microarray expression ratios.
His-Bind resin coated with recombinant integrin tails. Beads were 
washed and bound proteins fractionated by SDS-PAGE. and kindlerin 
was detected by Western blotting with FLAG antibodies. Loading of 
recombinant integrin tails onto the beads was assessed by Coomassie 
Blue staining.
sHINA Transfection—HaCaT cells were transfected using siPORT 
Amine (Ambion) with a 21-nucleotide irrelevant RNA (control) or with 
a 21-nucleotide RNA targeting the kindlerin sequence (onlv sense se­
quence is shown): 5'-GAA GUU ACU ACC AAA AGC UTT.'Cells were 
harvested -4 4  h after adding siRNA duplexes and examined for 
kindlerin expression by Western blot analysis. To show equivalent 
loading of protein, the membrane was probed with a talin monoclonal 
antibody (Sigma).
Cell Spreading—Approximately 44 h after addition of the siRNA 
duplexes, cells were trypsinized and washed 2 times in Opti-MEM 
(Invitrogen). Cells were plated on fibronectin (10 /iig/ml, Sigma)-coated 
coverslips and were allowed to spread for 30 min at 37 °C, 5% C 02. Cells 
were stained by indirect immunofluorescence as described above using 
talin and vinculin antibodies. A minimum of four randomly selected 
fields (-180 cells total) was recorded with a digital camera. The area of 
cell spreading visualized by talin immunofluorescence was measured 
using Openlab software.
RESULTS
TG F-p T rea tm ent Increases K ind lerin  Expression—TG F-0 
elicits its  biological effects by activation  of a  SM A D -dependent 
tran scrip tio n a l program  (review ed in Refs. 3 0 -33 ). To identify  
po ten tia l dow nstream  ta rg e ts  of TG F-0 signaling  th a t  a re  in ­
volved in  EM T and  cell m igration , w e u sed  m icroarray  analysis 
to com pare th e  tran scrip tio n a l profiles of HM EC tre a te d  w ith  
10 ng/m l TG F-0 to those of veh ic le-trea ted  cells. Seventeen 
genes exhibited  a  g rea te r th a n  1.5-fold induction  an d  a p  va lue  
of less th a n  0.05 (Table I). Induced  genes included  a  nu m b er of 
know n TGF-j3-responsive genes w ith  roles in cell m otility  and  
adhesion such as plasm inogen ac tiva to r in h ib ito r type I (34, 
35), tran sg lu tam in ase  (36), throm bospondin  1 (37), and  fi­
b ronectin  (35). W e exam ined Table I for novel genes w ith  p re ­
dicted roles in cell adhesion and  m igration , and  w e recognized 
th a t  th e  th ird  ran k in g  gene encoded k ind lerin , a  p ro tein  r e ­
qu ired  for stab le  a tta c h m e n t of epithelia l cells to  th e  lam in a  
densa  (1). K ind lerin  d isplays s im ila rity  th ro u g h o u t its  se ­
quence to tw o o th er hu m an  p ro teins, Mig-2 (65% iden tity  ) and  
U RP2 (57% identity ), as show n in Fig. 1 and  ap p ears  to be 
re la ted  to th e  C. elegans p ro tein , U NC-112 (44% identity). 
UNC-112 is requ ired  for th e  o rganization  of dense bodies and  
a tta c h m e n t of m uscle cells to th e  hypoderm is, and  UNC-112 
in te rac ts  genetically  w ith  in teg rin s  (20). T hus we focused on 
k ind lerin  as a  possible m ed ia to r of TG F-0 effects on in teg rin  
function.
In  o rder to verify th e  induction  of th e  k ind lerin  gene by 
TG F-0, mRNA w as iso lated  every 2 h u p  to  12 h a fte r tre a tm e n t 
w ith  TG F-0 an d  exam ined by N orthern  blot ana ly s is for 
k ind lerin  expression (Fig. 2A). A 4.6-kb k ind lerin  mRNA tr a n ­
scrip t w as induced ~  10-fold 6 h  a fte r  add ition  of TGF-0. The 
level of k ind lerin  tra n sc r ip t rem ained  elevated  a fte r  exposure 
to TG F-0 for 96 h (d a ta  n o t shown). To exam ine th e  role of 
p ro tein  syn thesis  in regu la tion  of k ind lerin  mRNA, w e exam ­
ined  th e  effect of cycloheximide on TG F-0 s tim u la ted  HM EC. 
K indlerin  mRNA abundance  w as m arked ly  increased  by th e  
addition  of TG F-0 (Fig. 2B ). A ddition of cycloheximide sign ifi­
can tly  reduced  th e  effect of TG F-0 on k ind lerin  mRNA, in d i­
ca ting  th a t  p ro tein  syn thesis  is requ ired  for th e  TG F-0 s tim u ­
lation  of k ind lerin  tran scrip tion . T hus, k ind lerin  is a  TGF-0- 
inducible gene.
We n ex t assessed  th e  effect of TGF-0 on th e  abundance  of th e  
k ind lerin  p ro tein . We ra ised  polyclonal antibodies d irected  
ag a in s t a  bacte ria lly  expressed p ro tein  fragm en t con tain ing  
am ino acids 5 0 0 -6 7 7 . W estern  im m unoblot ana ly s is shows 
th a t  th e  k ind lerin  an tise ru m  specifically recognizes a  p ro tein  
w ith  an  a p p a re n t m olecular w eigh t of 64,000 (Fig. 3A) in 
H M EC and  H aC aT  lysates. B ecause H aC aT  and  H M EC re ­
spond to TG F-0 and  express k ind lerin , these  cell lines w ere 
u sed  for our s tud ies  of th e  endogenous p ro tein . T he an tise ru m  
did no t recognize two k ind lerin  paralogues, Mig-2 and  U RP2, in 
m ouse fibroblasts tran sfec ted  w ith  FLAG-Mig-2 or FLAG- 
U RP2 cDNA (d a ta  n o t shown); therefore , th e  an tise ru m  is 
specific for k ind lerin .
To determ ine  w h e th e r TG F-0 increases k ind lerin  p ro tein  
levels, H M EC (Fig. 3B ) and  H aC aT  cells (d a ta  n o t show n) w ere 
tre a te d  w ith  TGF-0, and  ly sa tes w ere p rep a red  a t  various tim e 
po in ts up  to 48 h a fte r  in itia tion  of tre a tm e n t. K indlerin  levels 
increased  sligh tly  a t  8 h, significantly  a t  24 h, an d  m ost d ra ­
m atica lly  a t  48 h a fte r  TG F-0 tre a tm e n t. The induction  of 
k ind lerin  by TG F-0 reached  a  p la teau  a t  48 h and  rem ained  
elevated  for u p  to 96 h (d a ta  n o t shown). The m em brane  w as 
strip p ed  and  probed w ith  v inculin  antibodies to norm alize for 
equal p ro te in  levels. K indlerin  expression w as q u a n tita te d  re l­
ative  to  v inculin  abundance  a t  th e  ind ica ted  tim e po in ts (Fig. 
3C). P robing  a  paralle l b lo t w ith  E -cadherin  an tibodies show ed 
a  decrease in expression upon TG F-0 trea tm en t, w hich is in ­
dicative of cells undergoing  EMT. A dditionally , exposure of 
H M EC to TG F-0 for 48 h induces a  change from a  round, 
com pact ep ithelia l shape  to a  fla ttened  fibroblast-like m orphol­
ogy (Fig. 3D). T his change in  morphology is consisten t w ith  
those observed for cells undergoing  EM T in response to  TGF-0. 
T hese re su lts  d em onstra te  th a t  k ind lerin  levels increase in  th e  
presence of TG F-0 and  ind ica te  th a t  k ind lerin  m ay ac t as a  
dow nstream  m ed ia to r of TG F-j3-initiated EMT.
K ind lerin  Is  a C onstituen t o f  Focal A dhesions—EM T resu lts  
in  increased  cell m otility  an d  a  reo rgan iza tion  of th e  cytoskel­
eton (5, 6). The k ind lerin  orthologue, UNC-112, co-localizes 
w ith  in teg rin  adhesion recep tors a t  dense bodies in  th e  body 
w all m uscle of C. elegans and  is requ ired  for th e  proper orga­
n ization  of in teg rin  complexes a t  th e  s ite  of m uscle a tta ch m en t 
to th e  hypoderm is (20). D ense bodies in  w orm s and  focal ad h e ­
sions in  m am m alian  cells sh a re  m any  common com ponents 










1 m----------- LSSTDFTFASWELVVRVDHPNEEQQKDVTLRVSGDLHVGGVMLKLVEQINISQ Kindlerin
1 MALDGIRMPDGCYADGTWELSVHVT------- DLNRDITLRVTGEVHIGGVMLKLVEKLDVKK Mig-2
1 MA--GMKTASGDYIDSSWELRVFVGEEDPEAES- VTLRVTGESHIGGVLLKIVEQINRKQ URP2
1 MA-----HLVEGTS11DGKWQLPI LVT------- DLNI QRS ISVLGNLNVGGLMLELVSECDVER UNC-112












Fig. 1. C om parison of th e  am ino 
acid  sequences of k in d le rin  paral- 
ogues and  UNC-112. Amino acid align­
ment of kindlerin. Mig-2. URP2. and 
UNC-112. Identical amino acids are high­
lighted in black, and dashes indicate gaps 
in the alignment. The amino acid se­










156 --N K E P IIE D ILN LE --------- SSPTASGSSV----- SPGL................- YSKTMTPX------YDPI Kindlerin
158 --Q SE----- DEALELE--------- GPLITPGSGSIYSSPGL................-YSKTMTPT------YDAH Mig-2
156 --E P E ----- EELYDLS--------- KWLAGG----------VAPAL--------------- F----------------------------URP2
174 LRKAAPIFASQSNLDMRRRGQSPALSQSGHIFNAHEMGTLPRHGTLPRGVS PSPGAYNDT UNC-112
195 NGTPASSTMTWFSDSPLTEQNCSILAFSQPPQSPEALADMYQPRSLVDKAKLNAGWLDSS Kindlerin
197 DGSPLSPTSAWFGDSALSEGNPGILAVSQPITSPEILAKMFKPQALLDKAKINQGWLDSS Mig-2
179 RGMPAH--------- FSDSAQTEACYHMLSRPQPPPDPLLLQRLPRPSSLSDKTQLHSRWLDSS URP2








353 FAALQ - LQATLQRDSPEPEENNKDDVDILLDELEQNLDAAALNRR-SDLTQVPELA UNC-112
374 DNLKLFRPKKLL-PKAFKQYWFIFKDTSIAYFKNKELEQGEPLEKLNLRGCEWPDVNVA Kindlerin
377 DYIKVFKPKKLT-LKGYKQYWCTFKDTSISCYKSKEESSGTPAHQMNLRGCEVTPDVNIS Mig-2






493 LRMK--------NRNSASQVA------ SSLENMDMNPECFVS PRCAKRHKSKQ - LAARILEAHQN Kindlerin
496 LKMQ--------HLNPDPQLI------ PEQITTDITPECLVSPRYLKKYKNKQ- ITARILEAHQN Mig-2
473 LSLQ--------RTGSGGPGNHPHGPDASAEGLNPYGLVAPRFQRKFKAKQ-LTPRILEAHQN URP2
527 LKMQSGNGNENGNSNTASRKAAAVKLPNDFNVDEYISSKYVRRARSKQQIQQRVSDAHGN UNC-112
543 VAQMPLVEAKLRFIQAWQSLPEFGLTYYLVRFKGSKKDDILGVSYNRLIKIDAATGI PVT Kindlerin 
546 VAQMSLIEAKMRFIQAWQSLPEFGITHFIARFQGGKKEELIGIAYNRLXRMDASTGDAIK Mig-2 


























Fig. 3. A ntibody ch a rac te riza tio n  and  k in d le rin  expression  in  
TGF-jS-treated HMEC. A. Western blot analysis of HMEC and HaCaT 
lysates (25 /ng) using pre-immune (left panel) or kindlerin antiserum 
(right panel), B, time course analysis of HMEC treated with TGF-p. 
Lysates (15 /ng) were probed with kindlerin. vinculin. and E-cadherin 
antibodies. C, quantification of kindlerin induction by TGF-p normal­
ized to vinculin levels. D, phase contrast images of HMEC treated with 
vehicle (control) or TGF-p for 48 h. Images were taken at the same 
magnification.
sions in  m am m alian  cells, im m unofluorescence w as perform ed 
using  an  affin ity-purified  k ind lerin  an tibody to detec t endoge­
nous k ind lerin . As can be seen in  Fig. 4, k ind lerin  w as concen­
tra te d  in  focal adhesions w here i t  co-localizes w ith  vinculin . 
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Fig. 2. TG F-p  tre a tm en t o f HMEC. A. Northern blot analysis of 
kindlerin and GAPDH using mRNA isolated from HMEC treated with 
vehicle (V) or TGF-p for the indicated time. B. HMEC were treated with 
vehicle ( - )  or TGF-p (+) for 3 h. and total RNA was isolated. In parallel 
cultures, cycloheximide (CHX) was added to the cells 15 min prior to the 
addition of TGF-p. Expression levels of kindlerin and GAPDH were 
analyzed by Northern blot.
Fig. 4. Localization  of k in d le rin  in  m am m alian  cells. Indirect 
immunofluorescence analysis of HaCaT cells using kindlerin (A) and 
vinculin (B) antibodies. C is a merged image of A  and B. White arrows 
indicate sites of focal adhesions. D shows combined staining of kindlerin 
(red) and F-actin (green). Yellow arrows point to kindlerin localization 
at the ends of actin filaments. HaCaT cells stained with control (E) and 
vinculin (F) antibodies.
focal adhesions in  several cell types, includ ing  specialized ep i­
the lia l cells such as kera tinocy tes (3 9 -4 3 ). V isualization  of 
filam entous ac tin  by fluorescen t phallo id in  d em onstra ted  th a t  
k ind lerin  is p re sen t a t  th e  tip s  of ac tin  fibers (Fig. 4D). No focal 
adhesion s ta in in g  w as detec ted  w ith  a  control an tibody (Fig. 
4E )  even though  focal adhesions a re  p re sen t an d  observed 
using  a  v inculin  an tibody (Fig. 4F). K ind lerin  w as no t detec ted  
a t  cell-cell ju n c tio n s th a t  w ere  com pared by s ta in in g  w ith  E- 
cadherin  antibodies (d a ta  no t shown). T hus, k ind lerin  is a 
co n stitu en t of focal adhesions.
K ind lerin  Localizes to M em brane R u ffles  upon TG F-fi Trea t­
m en t—O ur d a ta  show th a t  k ind lerin  is a  focal adhesion protein  
w hose expression is reg u la ted  by TGF-p. In  o rder to ga in  in ­
s ig h t in to  th e  role o f k ind lerin  in  T G F-p-m ediated  cytoskeletal 
reo rgan ization , we exam ined its  localization in H aC aT  cells 
exposed to vehicle (Fig. 5, A  and  B )  or TG F-p (Fig. 5, C  and  D) 
and  co-stained w ith  fluorescen t phallo id in . A fter 48 h of TG F-p 
stim u la tion , a m ark ed  increase  in  cell sp read ing  occurred, in ­
d icative of th e  tran s itio n  from an  ep ithelia l to a  m esenchym al 
cell morphology. In  veh ic le-trea ted  cells, th e  actin  cytoskeleton 
w as organized as a  ne tw ork  of filam en ts th a t  circum scribes 
each cell colony. A fter exposure to TG F-p, ac tin  filam en ts w ere 
reorganized  to estab lish  ac tin  a rray s  th a t  a re  typical of fibro­
b lastic  cells. A  fraction of k ind lerin  rem ained  in  focal adhesions 
and  localized to th e  ends of actin  fibers, b u t th e re  w as a no tab le  
increase  in  k ind lerin  expression  in  a  m ore diffuse cytoplasm ic 
s ta in in g  p a tte rn . C o-stain ing  H aC aT  cells w ith  k ind lerin  and  
v inculin  an tibodies revealed  a d ifferential responsiveness of 
these  two focal adhesion con stitu en ts  to TG F-p tre a tm e n t (Fig. 
6). A fter TG F-p tre a tm en t, a  sign ifican t loss of coincidence of 
k ind lerin  and  vincu lin  w as observed in m any  b u t no t all focal 
adhesions (Fig. 6, D -D . TG F-p re su lted  in  an  en richm en t of 
k ind lerin  in  m em brane ruffles p a rticu la rly  a t  s ites  of contac t 
w ith  o ther cells. T he focal adhesion constituen t, v inculin , r e ­
m ained  p re sen t a t  ex trace llu la r m a trix  a tta ch m en t sites  in d i­
ca ting  th a t  focal adhesions had  no t been dissolved.
F E R M  D om ain o f  K ind lerin  Is  H igh ly  S im ila r  to the F E R M  
D om ain o f  Ta lin —As described above, k ind lerin  localizes to 
focal adhesions, and  ana ly s is of th e  k ind lerin  am ino acid se ­
quence suggests a ra tio n a le  for th is  localization. A  search  for 
conserved dom ains revealed  th a t  a s tr ik in g  fea tu re  of k ind lerin  
is homology of two regions o f th e  p ro te in  w ith  the  FERM  (four 
po in t one ezrin  rad ix in  and  m oesin) dom ain (Fig. 7A , gray, 
green, and  blue boxes) and  a p red icted  p leckstrin  homology 
dom ain (Fig. 7A , black box). In te resting ly , th e  p leckstrin  ho­
mology dom ain s its  in  the  m iddle o f a  p u ta tiv e  contiguous 

























Fig. 5. The effect of TGF-fi tre a tm e n t on  k in d le rin  d is trib u tio n  
and  th e  ac tin  cytoskeleton . Staining patterns of kindlerin (red) and 
F-actin (green) in the absence (A and B) and presence (C and D) of 
TGF-j3 in HaCaT cells. The images in A -D  are shown at the same 
magnification, and the bar indicates 50 /xm.
sh a red  by th e  m em bers of th e  k ind lerin  fam ily includ ing  Mig-2 
and  URP2.
Among o th e r FERM  dom ain pro te ins, th e  k ind lerin  FERM  
dom ain h a s  th e  h ighes t s im ila rity  to th e  FERM  dom ain of ta lin  
(44), an  in teg rin -b ind ing  p ro tein  th a t  localizes to focal ad h e­
sions (29). In  o rder to gain  in s ig h t in to  th e  function of th e  
FERM  dom ain of k ind lerin , w e aligned th e  am ino acid se ­
quence of these  corresponding regions in  ta lin  and  k ind lerin  
( Fig. IB ). T he gray box a t  am ino acid 250 in  k ind lerin  ( Fig. 7A ) 
il lu s tra te s  w here  th e  s im ila rity  to ta lin  begins. FERM  dom ains 
a re  composed of th ree  subdom ains ( F I ,  F2, and  F3) a rran g ed  in 
a  cloverleaf p a tte rn  (45) and  often m ed ia te  in te rac tions w ith  
th e  cytoplasm ic dom ains of tran sm em b ran e  proteins. T he re ­
gions s im ila r to th e  F2 and  F3 subdom ains of ta lin  a re  in d i­
cated  by green  and  blue, respectively. T he s tru c tu re  of th e  F2 
and  F3 subdom ains of ta lin  h a s  been solved ( 4), and  alignm en t 
of k ind lerin  and  ta lin  FERM  dom ains p red ic ts th a t  th e  PH  
dom ain lies in  th e  la rge  loop betw een th e  second an d  th ird  
a-helix  o f th e  F2 subdom ain. In  ta lin , th is  region does not 
compose any  of th e  core s tru c tu re  of th e  F2 dom ain. P H  do­
m ain s (Conserved D om ain d a ta  base: sm art00233) can be in ­
se rted  in to  o th er dom ains th a t  re ta in  activ ity  (w w w .ncbi.nlm . 
nih.gov/S tructure/cdd/); therefore, i t  is p lausib le  th a t  k ind lerin  
houses a functional P H  dom ain w ith in  a  s tru c tu ra lly  in tac t 
FERM  dom ain.
T he m u ta tio n s  iden tified  in  K ind ler syndrom e (as ind icated  
by asterisks  in  Fig. 7A )  yield tru n ca ted  form s of k ind lerin , all of 
w hich com prom ise th e  in teg rity  of th e  FERM  dom ain (1). The 
longest d isease-associated  gene p roduct is p red icted  to g en er­
a te  a  p ro te in  iden tical to k ind lerin  th rough  the  f irs t 572 (arrow  
in  Fig. IB )  am ino acids followed by th ree  un ique  am ino acids 
(1). T he re su ltin g  p ro te in  con ta ins only five am ino acids of th e  
p red icted  F3 subdom ain, ind ica ting  th e  essen tia l role of th e  F3 
subdom ain  for k ind lerin  function.
T he sequence s im ila rities  betw een F3 subdom ains of ta lin  
and  k ind lerin  pe rm itted  u s  to build  a re liab le  th ree-d im en­
sional model of th e  k ind lerin  F3 subdom ain  (Fig. 7 0 .  As judged  
by th e  p rogram  W HAT-IF (27), th e  model h a s  norm al inside/ 
outside d is tribu tion  of hydrophobic/hydrophilic res idues (Z 
score 1.005) and  struc tu ra l packing quality  (Z score —1.135), and 
th e  R am achandran  Z score (—0.371) is w ith in  th e  range of well 
refined structu res. Com parison of the  model w ith  ta lin  F3 gives a 
root m ean square of 1.32 A  for 88 C a atom s. Thus, the  phospho­
tyrosine binding-like fold of F3 subdom ains is com patible w ith 
th e  sequence of th e  pu ta tive  F3 subdom ain of kindlerin.
T he m ajo r in teg rin -b ind ing  s ite  in  ta lin  lies w ith in  th e  F3 
subdom ain  (46). A m ino acids pa rtic ip a tin g  in  th is  in terac tion  
(4) a re  boxed in  Fig. IB ,  and  th e  corresponding am ino acids in  
k ind lerin  a re  sim ila r or iden tical. M odeling of th e  k ind lerin  F3 
dom ain fu r th e r  h igh ligh ts th a t  m any  of th e  res idues conserved 
betw een ta lin  and  k ind lerin , ind ica ted  by th e  teal color in  th e  
k ind lerin  m odel, a re  c lustered  in  th e  in teg rin  b ind ing  region of 
th e  F3 subdom ain  (Fig. 7 0 .
fi In tegrin  C ytoplasm ic D om ains F orm  Complexes w ith  
K ind lerin —T he am ino acid conservation  betw een th e  ta lin  and  
k ind lerin  FERM  dom ains, p a rticu la rly  w ith in  th e  region re ­
sponsible for b inding to in teg rin  fi ta ils , led u s  to hypothesize 
th a t  k ind lerin  m ay  b ind to in teg rin s. To te s t th is  hypothesis, 
ly sa tes from C hinese h a m s te r ovary cells expressing  exogenous 
FLA G -kindlerin  w ere incubated  w ith  recom binan t fi in teg rin  
ta ils  (Fig. 8A). K ind lerin  w as iso la ted  w ith  e ith e r th e  J31A or fi3 
in teg rin  cytoplasm ic dom ain. T he association w as specific a s  no 
k ind lerin  w as iso la ted  w ith  th e  cytoplasm ic dom ain of in teg rin  
« jjb. T yrosine to a lan ine  m u ta tio n s  w ith in  th e  conserved in te ­
g rin  NPXY m otifs, w hich a re  know n to d is ru p t a fi tu rn  (47) 
requ ired  for ta lin  b ind ing  (46), also significantly  reduced 
k ind lerin -in teg rin  in terac tions. F u rth e rm o re , th e  b inding of 
k ind lerin  to th e  cytoplasm ic dom ain of in teg rin  fi3 is dose-de­
p enden t (Fig. 8B ). M axim um  b inding  w as observed w ith  50 /ug 
of ly sa tes. H ence, focal adhesion localization of k ind lerin  m ay 
be m ed ia ted  by FERM  dom ain-in tegrin  fi ta il in terac tions.
B inding of F3 subdom ain  of ta lin  to th e  cytoplasm ic dom ains 
of fi3 in teg rin s  leads to an  increase  in  in teg rin  affin ity  for 
ligand  (in tegrin  activation  ) (46, 48). T he s im ila rity  of k ind lerin  
to th e  FERM  dom ain of ta lin , in  both am ino acid sequence and  
ability  to b ind th e  cytoplasm ic dom ain of fi in teg rin s, therefore 
prom pted  u s  to exam ine th e  effect of overexpressed k ind lerin  
on « IIbA3 activation . K indlerin  expression h ad  no effect on 
a IIbj33 activation  (d a ta  no t shown). T h is finding is  s im ila r to 
N um b and  D ok l, o ther in teg rin  fi ta il-b ind ing  pro te ins con ta in ­
ing  homology to th e  F3 dom ain of ta lin , w hich a re  also unab le  
to ac tiva te  in teg rin s  (46).
K ind lerin  Is  Invo lved  in  Cell Spread ing—T he preceding d a ta  
show th a t  k ind lerin  is  an  in teg rin -assoc ia ted  focal adhesion 
protein . To assess th e  function  of k ind lerin , we em ployed sm all 
in te rfe rin g  RNA (siRNA) duplexes to reduce th e  expression  of 
k ind lerin  in  h u m an  cells. K indlerin  p ro te in  w as reduced in 
ly sa tes p rep a red  from H aC aT  cells tran sfec ted  w ith  k ind lerin  
siRNA as com pared w ith  ly sa tes p rep a red  from cells tr a n s ­
fected w ith  an  ir re le v an t siRNA as show n by W estern  b lo t (Fig. 
9A). T he m em brane w as strip p ed  and  probed for ta lin  to dem ­
o n stra te  equal p ro tein  levels in  both lanes. Forty-four hours 
a fte r  transfec tion  of th e  siRNA duplexes, cells w ere rep la ted  on 
fibronectin-coated coverslips and  allowed to sp read  for 30 m in. 
Ind irec t im m unofluorescence analysis u sing  ta lin  an tise ru m  
revealed  a decrease in  th e  ab ility  of k ind lerin  siRNA cells to 
sp read  a s  com pared w ith  control cells (Fig. 9B). To quan tify  th e  
change in  cell sp read ing , th e  cell a rea  w as m easu red  for - -200 
cells (Fig. 9 0 .  T he m ean  cell a rea  w as 712 /um2 for control 
siRNA cells and  452 /um2 for k ind lerin  siRNA cells. T hus, 
reduction  in  k ind lerin  levels affects cell sp reading.
DISCUSSION
In th is  report, w e have explored th e  m olecular m echanism s 
underly ing  th e  ce llu la r response to TGF-J3. W e p re sen t th e  
following data : (i) k ind lerin  expression  is increased  following 
s tim u la tion  w ith  TGF-J3; (ii) k ind lerin  is  a  co n stitu en t of focal 
adhesions; (iii) th e  in teg rin -b ind ing  res idues found in  ta lin  are  
conserved in  k ind lerin ; (iv) k ind lerin  can be iso lated  in  fi in te ­
g rin  ta il complexes; and  (v) k ind lerin  is requ ired  for norm al cell 
spread ing .



















F ig . 6. The effect o f TGF-p trea t­
m ent on kindlerin  distribution and 
vinculin localization. Indirect immuno­
fluorescence analysis of kindlerin {red) 
and vinculin {green) in the absence (A-C,I 
or presence (D-I) of TGF-p. The images in 
A -F  are shown at the same magnification, 
and the bar indicates 50 /xm. G-l repre­
sent enlarged images of the boxed regions 
in D-F. Yellow arrows indicate sites of 
kindlerin-enriched staining, and white ar­
rows point to focal adhesions stained by 
vinculin antibodies.
Fig. 7. Com parison o f ta lin  and 
kindlerin  FER M  domains. A, linear di­
agram of kindlerin. The FERM domain is 
shown ingreen and blue to indicate the F2 
and F3 subdomains, respectively; and the 
gray box indicates homology to talin be­
fore the predicted start of the F2 subdo­
main. The PH domain is indicated by a 
black box. Mutations identified in Kindler 
syndrome by Jobard et al. (1) are indi­
cated by asterisks at amino acids 128 ,154, 
262, and 572. B, alignment of kindlerin 
and talin FERM domains. The primary 
sequences of kindlerin and chicken talin 
were aligned by blast searching and re­
fined using structure-based alignments 
performed by Swiss-PbdViewer (us.expasy. 
org/spdbv/J. Identical residues are marked 
with * and similar residues with . below the 
alignment. The arrow indicates residue 572, 
site of one of the mutations identified in Kin- 
dler syndrome. The boxed residues in talin 
mediate the p integrin-talin interaction. 
Kindlerin exhibits sequence similarity to the 
talin FERM domain, and the talin FERM 
subdomains F2 and F3 are highlighted in 
green and blue, respectively. Kindlerin con­
tains a large insertion, residues 326-495, 
containing a predicted PH domain, within 
the putative FERM domain. These amino 
acids are not shown in the alignment. C', 
model of the kindlerin F3 subdomain. Rib­
bon representations of the homology model 
of the kindlerin F3 subdomain (left) and of 
the talin F3 subdomain structure with the 
integrin ligand in green (Protein Data Bank 
code 1MK7; right). Regions of kindlerin ex­
hibiting primary sequence similarity to 
talin are colored teal. Modeling was per­



























Fig . 8. I n t e g r in  fi t a i l s  fo r m  c o m p le x e s  w ith  k in d le r in .  A, cell 
lysate (150 jiig) containing FLAG-tagged kindlerin was mixed with 
beads coated with recombinant integrin cytoplasmic tails or tails con­
taining point mutations as indicated. Bound proteins were fractionated 
by SDS-PAGE and binding of kindlerin assessed by Western blotting 
with anti-FLAG antibodies. Loading of recombinant integrin tails onto 
the beads was assessed by Coomassie Blue staining. B, increasing 
amounts of cell lysate containing FLAG-tagged kindlerin were incu­
bated with integrin tails and analyzed as in A.
our microarray data for genes that may be involved in TGF-/3- 
stimulated migration. Several pieces of circumstantial evi­
dence prompted us to investigate a possible role for kindlerin in 
mammalian cell adhesion and migration. First, kindlerin con­
tains two regions of homology with the FERM domain with a 
PH domain inserted inbetween the two. The FERM domain has 
been identified in several molecules such as ezrin, radixin, and 
moesin that connect the cytoplasmic domains of transmem­
brane proteins to the actin cytoskeleton (44). Other proteins 
that display FERM domains are involved in cell migration 
including focal adhesion kinase and talin (49). A second clue 
about the potential function of kindlerin stems from studies of 
an apparent orthologue in C. elegans, UNC-112. UNC-112 null 
worms exhibit the paralyzed arrested at 2-fold phenotype, a 
phenotype that is shared by a  and fi integrin, integrin-linked 
kinase, and perlecan (20). GFP-UNC-112 rescued embryonic 
lethality and co-localized with integrins a t dense bodies in the 
body wall muscle (20). In the absence of UNC-112, a  integrin 
failed to localize to the membrane in body wall muscle (20). 
Moreover, UNC-112 was not properly targeted to the mem­
brane in worms lacking a  integrin implying an interdepen­
dence of UNC-112 and a  integrin for organization of dense 
bodies (20). The unique domain architecture of kindlerin and 
the elegant genetic studies of unc-112 led us to hypothesize 
that kindlerin is involved in mammalian cell adhesion and 
migration.
We characterized kindlerin as a protein whose expression 
increases significantly in the presence of TGF-/3. Our studies 
indicate that enhanced transcription of the kindlerin gene is 
most likely a secondary response to TGF-J3 stimulation because 
its induction is markedly reduced in the presence of the protein 
synthesis inhibitor cycloheximide. Additionally, peak levels of
F ig. 9 . T h e  e f f e c t  o f  k in d le r in  k n o c k -d o w n  o n  c e l l  s p r e a d in g .
A, Western blot analysis of lysate (20 /ng) from control or kindlerin 
siRNA transfected HaCaT cells probed with kindlerin antiserum (left 
panel). The membrane was stripped and probed with talin antibodies 
(right panel) to demonstrate equivalent protein levels. B, indirect im­
munofluorescence analysis of control (left panel) or kindlerin (right 
panel) siRNA transfected HaCaT after plating on fibronectin-coated 
coverslips for 30 min using talin antiserum. C, the cell area of —200 
cells was measured by recording images of talin immunofluorescence. 
The p  value is less than 0.0001 using a two-tailed unpaired t test. The 
data are representative of three independent experiments.
kindlerin mRNA and protein occurred at 6 and 48 h, respec­
tively, after treatment with the cytokine. At 12 h when the 
levels of kindlerin began to increase, levels of E-cadherin, a 
marker for EMT, began to decline. Other reports have shown 
that EMT has taken place in HaCaT cells after 48 h of exposure 
to TGF-J3 (50), and the reduction of E-cadherin expression 
indicated that our cells were responding in a similar fashion. 
The increase in kindlerin levels occurred during the later 
stages of EMT progression, and these data suggest that 
kindlerin may be involved in the downstream events of the 
TGF-J3 response.
Indirect immunofluorescence analysis of kindlerin in HaCaT 
demonstrated that endogenous kindlerin localizes to focal ad­
hesions in mammalian cells. After TGF-J3 stimulation, 
kindlerin is also detected at membrane ruffles particularly at 
sites of cell-cell contact. The presence of kindlerin a t focal 
adhesions is consistent with its isolation in integrin complexes 
and implies a role in cell-matrix adhesion. A kindlerin-related 
protein, Mig-2, has also been shown to localize to focal adhe­
sions and is involved in regulating cell shape and cell spreading 
(51). Mig-2 interacts with a protein termed migfilin, which 
potentially could connect Mig-2 to filamin and the actin cy­


























ent with our findings on kindlerin and supports a general role 
for the Mig-2 family in cell adhesion. To date, no reports have 
described URP2 function; however, its high expression levels in 
spleen, thymus, and peripheral blood leukocytes suggest a role 
specific to the immune system (2). Future experiments will be 
needed to address the role of the enrichment of kindlerin at 
membrane ruffles and sites of cell-cell contact in altered adhe­
sion, migration, and morphology of TGF-/3-treated cells.
Based on the homology of the FERM domain of kindlerin 
with talin and the genetic interaction in C. elegans between 
UNC-112 and integrins, we suspected that kindlerin interacts 
with the cytoplasmic domain of the fi integrin subunit. In 
support of this hypothesis, recombinant structural mimics of 
/31a and f}3 integrin cytoplasmic domains were able to isolate 
exogenously expressed FLAG-kindlerin. Although these exper­
iments do not demonstrate a direct interaction between 
kindlerin and fi integrin, similarity with talin and the absence 
of kindlerin binding to the integrin fi cytoplasmic domains 
containing tyrosine to alanine mutations suggests that a direct 
interaction via the FERM domain of kindlerin is likely. We 
were unable to confirm tha t the FERM domain was responsible 
for this interaction because of the insolubility of C-terminal 
kindlerin fragments (data not shown) and the low expression of 
N-terminal kindlerin fragments (data not shown).
Reduction of kindlerin by siRNA resulted in delayed cell 
spreading. Adhesion was not affected by kindlerin knock-down 
when tested 30 min after replating on fibronectin or laminin 
(data not shown). Therefore, it is unlikely that kindlerin is 
required for integrin-ligand interaction. The biochemical inter­
action between kindlerin and the cytoplasmic domains of fi 
integrins may contribute to efficient linkage of the extracellu­
lar matrix to the actin cytoskeleton via integrin adhesion re­
ceptors. Moreover, the fact that kindlerin expression does not 
lead to integrin activation suggests that the impact of kindlerin 
on cell spreading occurs after integrin-ligand binding. Whether 
kindlerin is affecting the formation of the actin cytoskeleton to 
enable cell spreading or the assembly of the extracellular ma­
trix to build focal adhesion attachment sites remains to be 
elucidated.
The kindlerin gene was recognized by linkage analysis as 
being mutated in a rare skin disease called Kindler syndrome. 
This disease is characterized by acral blistering, photosensitiv­
ity, and diffuse poikiloderma with cutaneous atrophy (1, 3 ) and 
shares some similarities in its clinical presentation with two 
subtypes of junctional epidermolysis bullosa that are caused by 
mutations in ae or fi4 integrin genes (18, 19, 52). Similar skin 
blistering phenotypes have been described in mice with dis­
rupted a 3 (53) (a major integrin partner for integrin in the 
basolateral membrane of keratinocytes), ae (54), and fi4 (55) 
integrin genes as well as in mice genetically modified to spe­
cifically knock-out integrin expression in skin (56, 57). Skin 
lesions of patients affected with Kindler syndrome have normal 
desmosomes, hemidesmosomes, and anchoring filaments, and 
the major defect lies in the organization of the basement mem­
brane tha t shows extensive reduplication and disruption of the 
lamina densa (58, 59). Interestingly, microscopic examination 
of skin from the a3 integrin null mice (60) and the conditional 
fiA integrin null mice (56, 57) also revealed a disorganized 
basement membrane. The disruption of the integrity of the 
basement membrane caused by genetic defects in a 3 and fi1 
integrin and kindlerin implicates these proteins in basement 
membrane assembly and maintenance and suggests that they 
are likely components of the same signaling pathway. TGF-fi 
not only enhances kindlerin expression as shown in this report 
but also increases the abundance of integrins (61, 62) and 
extracellular matrix constituents such as fibronectin, collagen,
and laminin (63-66). Therefore, it is reasonable to postulate 
that organization of the newly synthesized extracellular matrix 
components by integrin and kindlerin complexes may be an 
important step in TGF-/3-stimulated cell motility. All four of 
the mutations identified in Kindler syndrome create truncated 
proteins that have lost the F3 subdomain of the FERM domain, 
and three of the four mutations generate products lacking both 
FERM domains and the PH domain. This finding suggests that 
the F3 subdomain in kindlerin is necessary for stabilization of 
the basement membrane through formation of integrin 
complexes.
Kindlerin has also been implicated in human cancer as it was 
found to be significantly overexpressed in 60% of lung and 70% 
of colon carcinomas tested (2). Despite the similar domain 
topology shared with Mig-2 and URP2, only kindlerin gene 
expression was found to be up-regulated (2). Interestingly, 
many colon cancers have increased levels of TGF-/3 expression 
(67), which suggests that kindlerin is a TGF-/3-inducible pro­
tein in vivo and evokes the possibility that kindlerin is involved 
in tumor pathophysiology.
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